Market
Overview
Market Research Future (MRFR) has
published a report about the global influenza
diagnostics market share expects 5.3% CAGR during the forecast period between
2023-2032. In terms of cash, this market is expected to grow with USD 1.81 billion
by 2032. This report analyzes the market, potential for growth during the forecast period, market sizes around the world,
key players in the market, product
launches and latest research and development (R&D).
Influenza as an illness can cause severe
complications and mess up anybody's medical history. Influenza is of various
types and with a variety of deadly symptoms. Hence, early diagnosis of
influenza can reduce the chances of further complications. Therefore, with
World Health Organization (WHO) confirming about 600 million Influenza cases
worldwide, the services offering accurate Influenza diagnosis are going to be
in-demand always and become a part of a huge market in the medical sector.
Key
Players
Global
influenza diagnostics market players include Alere (USA), BD (USA), Becton
Dickinson (USA), BioMérieux SA (France), Cepheid (USA), Hardy Diagnostics(USA),
LifeSign LLC.(USA), Meridian Bioscience, Inc.(USA), Quidel Corporation (USA),
Roche Molecular Systems Inc.(Switzerland), and Sekisui Diagnostics (USA).
Market Segmentation
The global influenza
diagnostics market overview is segmented on
the basis of types, tests, and region.
The segmentation of types comprises of type A
flu, type B flu, type C flu. The three forms of type A are bird flu, seasonal
flu, and Swine flu. Bird Flu is known as
Avian Influenza which is caused by viruses adapted to birds. It can be caused
by eating infected birds. Seasonal flu is common cold whose viruses become
active only during the change of seasons as human body becomes adapt to the new
season slowly. Similar to bird flu, swine flu is an infection caused by any one
of several types of swine influenza viruses. Swine influenza virus (SIV) or
swine-origin influenza virus (S-OIV) are the viruses causing this infection.
These viruses are found in pigs. Type B flu is found only in humans. Influenza
type B viruses are not classified by subtype and do not cause pandemics. It is
caused by a genus called Influenzavirus B which is from the virus family
Orthomyxoviridae. Type C Influenza viruses are from Orthomyxoviridae family.
They are not as severe as Type A or B but can cause local epidemics.
On the basis of tests, the market has been
segmented into direct fluorescent antibody (DFA) tests, molecular tests,
nucleic acid sequence-based amplification (NASBA) tests, rapid influenza
detection tests (RIDT), serological assays, simple amplification-based assays
(SAMBA) and loop-mediated isothermal amplification-based assays (LAMP). RITD is
the most common test for influenza, as it can confirm influenza in just 30
minutes.
Serological assays are segmented into
primary serological tests, secondary serological tests, and tertiary serological
tests. Primary serological tests cover enzyme-linked
immunosorbent assay (ELISA), immunofluorescent
antibody technique (IFAT) and radioimmunoassay
(RIA). Secondary Serological tests include agglutination tests, complement
fixation tests (CFT), precipitation tests, serum neutralization tests (SNT) and
toxin-antitoxin test.
Regional Analysis
The regional segmentation of the global influenza
diagnostics market report is into the Americas (North America & South America),
Europe, Asia Pacific, and Middle East & Africa (MEA). North America is believed to be the largest market for
global influenza diagnostics due to advanced healthcare facilities and the
increasing presence of major market
players in this region. Compared to North America, South America is a moderately smaller market, but that is not
due to lack of demand but due to the lack of awareness, lack of advanced
technology and lesser budgets for healthcare. In North America, the largest
markets are Canada and the United States of America (USA).
After North America, Europe is the largest
market for influenza diagnostics. Here due to reasons same as North America,
Western Europe stands with the lion's share in Europe market, compared to
Eastern Europe. In Western Europe, the biggest
markets are France, Germany, Italy, Spain and the United Kingdom (UK), followed
by the rest of Europe.
During the forecast period, Asia Pacific
region is expected to experience large-scale
growth of influenza diagnostics market with China, India, Japan, and South
Korea emerging as major markets. Remarkable growth is also expected in the
remaining countries of the Asia Pacific region.
However, compared to the Asia Pacific, MEA is expected to have limited
growth, with Egypt, Saudi Arabia and the United
Arab Emirates (UAE) emerging as the best bets for influenza diagnostics market
investors. The low market in the MEA region is primarily due to the lack of technology and education.
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of Wantstats
Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
United States of America
